Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1798]
News [2687]
Articles [195]
Editorials [1]
Conferences [135]
elearning [13]
Update on the latest in PARP inhibitors for prostate cancer
Prof Axel Merseburger and Prof Bertrand Tombal
Update on the latest in PARP inhibitors for prostate cancer ( Prof Axel Merseburger and Prof Bertrand Tombal )
11 Jul 2022
Isatuximab + Pd in Difficult-to-Treat Patients with RRMM
Dr Maximilian Merz - Leipzig University, Leipzig, Germany
Isatuximab + Pd in Difficult-to-Treat Patients with RRMM ( Dr Maximilian Merz - Leipzig University, Leipzig, Germany )
11 Jul 2022
ASCO Direct Highlights 2022: prostate cancer highlights
Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA
ASCO Direct Highlights 2022: prostate cancer highlights ( Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA )
9 Jul 2022
The advances in the management of patients with Hodgkin lymphoma and non...
Dr Eduardo Sotomayor - H. Lee Moffitt Cancer Center & Research Institute...
The advances in the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma ( Dr Eduardo Sotomayor - H. Lee Moffitt Cancer Center & Research Institute, Florida, USA )
9 Jul 2022
Latest updates in hormone receptor positive HER2 negative breast cancer
Dr Mariana Chavez MacGregor - MD Anderson Cancer Center, Houston, USA
Latest updates in hormone receptor positive HER2 negative breast cancer ( Dr Mariana Chavez MacGregor - MD Anderson Cancer Center, Houston, USA )
8 Jul 2022
Isatuximab + Kd in RRMM: Depth of Response Results From the IKEMA Trial
Dr Maximilian Merz - Leipzig University, Leipzig, Germany
Isatuximab + Kd in RRMM: Depth of Response Results From the IKEMA Trial ( Dr Maximilian Merz - Leipzig University, Leipzig, Germany )
28 Jun 2022
War in Ukraine: Global cancer aid to support refugees
Dr Horia Vulpe , Dr Ruslan Baltaga
War in Ukraine: Global cancer aid to support refugees ( Dr Horia Vulpe , Dr Ruslan Baltaga )
21 Jun 2022
War in Ukraine: The International Brain Tumour Alliance's response to aiding...
Kathy Oliver - Chair and Co-Director, International Brain Tumour Alliance
War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis ( Kathy Oliver - Chair and Co-Director, International Brain Tumour Alliance )
21 Jun 2022
Ibrutinib plus venetoclax for 1-L treatment of CLL and small lymphocytic...
Dr Carol Moreno - University of Barcelona, Barcelona, Spain
Ibrutinib plus venetoclax for 1-L treatment of CLL and small lymphocytic lymphoma shows a clinically meaningful PFS ( Dr Carol Moreno - University of Barcelona, Barcelona, Spain )
21 Jun 2022
Rucaparib effective as maintenance therapy following first-line platinum-based...
Dr Bradley Monk - University of Arizona College, Tucson, USA
Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer ( Dr Bradley Monk - University of Arizona College, Tucson, USA )
21 Jun 2022
ASCO 2022: The latest in mRCC
Prof James Larkin, Dr Bernard Escudier, Prof Jens Bedke and Dr Toni Choueiri
ASCO 2022: The latest in mRCC ( Prof James Larkin, Dr Bernard Escudier, Prof Jens Bedke and Dr Toni Choueiri )
17 Jun 2022
Targeted therapy combinations with venetoclax superior to chemoimmunotherapy in...
Prof Barbara Eichhorst - The University of Cologne, Cologne, Germany
Targeted therapy combinations with venetoclax superior to chemoimmunotherapy in frontline CLL ( Prof Barbara Eichhorst - The University of Cologne, Cologne, Germany )
13 Jun 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation